STERIS (STE) Stock
NYQ · STE
205.04
Fundamentals
Market cap
$19.99B
Price / Earnings ratio
25.2x
Price / Sales ratio
3.4x
Price / Book ratio
2.8x
Return on assets
0.1%
Ex-Dividend date
4 Sep 2026
Last payment date
N/A
Dividend amount
$0.63
Dividend yield
1.3%
Debt / Equity ratio
N/A
Latest news
About STERIS
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. We help our customers create a healthier and safer world by providing innovative healthcare, life sciences and dental products and services.
SectorHealthcare
IndustryMedical Devices
Employees17,937
CEOMr. Daniel A. Carestio
IPO DateJun 1, 1992
HeadquartersMentor, OH
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Daniel A. Carestio | President, CEO & Director | 1973 |
| Ms. Karen L. Burton | Senior VP, CFO & Chief Accounting Officer | 1968 |
| Mr. John Adam Zangerle | Senior VP, General Counsel & Secretary | 1967 |
| Ms. Mary Clare Fraser | SVP & Chief Human Resources Officer | 1970 |
| Mr. Cary L. Majors | Senior VP & President of Healthcare | 1975 |
| Ms. Julie Winter | Vice President of Investor Relations & Corporate Communications | — |
| Ms. Lindsey McGowan | VP, Chief Compliance & Quality Officer | — |
| Ms. Julia K. Madsen | Senior VP & GM of Life Sciences | 1965 |
| Mr. Andrew Xilas | Senior VP & GM of Dental | 1965 |
| Mr. Kenneth E. Kohler | Senior VP & GM of AST | 1963 |
Fundamentals
Valuation
Market cap$19.99B
Price-to-sales ratio3.36
Price-to-book value2.81
Price-earnings ratio25.20
Return on Equity11.00%
Return on Sales0.19%
Return on Assets0.07%
PEG ratio1.74
Earnings Per Share
Earnings Per Share$8.21
Income Statement
Average volume609,805
EBITDA$1.59B
1 year high (52w)$269.44
1 year low (52w)$195.14
Dividend
Ex dividend date4 Sep 2026
Dividend amount$0.63
Dividend yield1.26%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



